ZELIRA THERAPEUTICS LIMITED

9.33%

41.0¢

Market Cap $4.877M

Healthcare Biotechnology

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Latest Threads

Tag

Subject

ZLD

Ann: Preliminary Final Report

29/08/25

457

29/08/25

Last post Mcdunk

457

ZLD

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

14/08/25

4.3K

14/08/25

Last post kitingtofa

4.3K

ZLD

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

30/07/25

703

30/07/25

Last post hotmumbo

703

ZLD

Ann: Zelira Therapeutics Secures R&D Loan Facility

24/07/25

768

24/07/25

Last post wgly

768

ZLD

Ann: Publication of ZLT-L-007 IRB Approved Observational Study

23/05/25

2.5K

23/05/25

Last post FiSaver

2.5K

ZLD

Ann: Full Conversion of $USD3.25M Convertible Notes in HOPE SPV

28/04/25

429

28/04/25

Last post

ASX News

429

ZLD

Ann: Investor Presentation

03/04/25

563

03/04/25

Last post

ASX News

563

ZLD

Ann: Application for quotation of securities - ZLD

01/04/25

364

01/04/25

Last post

ASX News

364

See All Discussions

Timeline

Preliminary Final Report
29 Aug 14:00	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 16:29	Share

Zelira Therapeutics Secures R&D Loan Facility
24 Jul 12:05	Share

Publication of ZLT-L-007 IRB Approved Observational Study
22 May 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
29 Apr 11:06	Share

Full Conversion of $USD3.25M Convertible Notes in HOPE SPV
28 Apr 08:23	Share

Investor Presentation
03 Apr 08:17	Share

Application for quotation of securities - ZLD
01 Apr 17:49	Share

Cleansing Prospectus
31 Mar 13:07	Share

Proposed issue of securities - ZLD
31 Mar 12:33	Share

Zelira secures $1 Million At-the-Market Funding Facility
31 Mar 08:18	Share

Appendix 4D & FY25 Interim Financial Report
26 Feb 20:14	Share

Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund
18 Feb 13:32	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 14:08	Share

Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche
28 Jan 08:25	Share

Change of Director's Interest Notice x 2
20 Jan 20:13	Share

Notification of cessation of securities - ZLD
17 Jan 17:19	Share

Change of Director's Interest Notice
19 Dec 17:55	Share

Notification regarding unquoted securities - ZLD
18 Dec 13:15	Share

Zelira to present at Automic Invest 2024 conference
20 Nov 08:51	Share

Proposed issue of securities - ZLD
14 Nov 17:34	Share

Results of Meeting
14 Nov 12:47	Share

2024 Annual General Meeting Presentation
14 Nov 11:02	Share

Appendix 4C Cash Flow Report
29 Oct 12:39	Share

September 2024 Quarterly Activities Report
29 Oct 12:39	Share

Letter to Shareholders
11 Oct 15:52	Share

Notice of Annual General Meeting/Proxy Form
11 Oct 15:51	Share

Investor Webinar - HOPE FDA Program Update
20 Sep 10:42	Share

Notice of Investor Webinar - HOPE FDA Program Update
18 Sep 08:18	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 41.0¢		Change 0.035(9.33%)		Mkt cap ! $4.877M

Open	High	Low	Value	Volume
37.5¢	43.0¢	37.5¢	$1.289K	3.122K

Buyers (Bids)

No.	Vol.	Price($)
1	1330	41.0¢

Sellers (Offers)

Price($)	Vol.	No.
43.0¢	6158	1

View Market Depth

No.	Vol.	Price($)
1	1330	0.410
1	6000	0.380
2	6190	0.375
1	8110	0.370
1	5479	0.365

Price($)	Vol.	No.
0.430	6158	1
0.440	87	1
0.450	246	2
0.470	2629	2
0.500	6720	4

Last trade - 15.44pm 12/09/2025 (20 minute delay)

ZLD (ASX) Chart

ZELIRA THERAPEUTICS LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Zelira Therapeutics (ASX:ZLD) raises $1.77m through US-based investors

15 Mar 2023 14:06 (AEDT)

Latest Articles

Zelira Therapeutics (ASX:ZLD) promotes Greg Blake as Executive Director

Zelira Therapeutics (ASX:ZLD) has promoted Greg Blake from VP - Global Head ofCommercial and Partnering to Executive Director.

Zelira Therapeutics (ASX:ZLD) secures US$8.6m in funding for HOPE clinical trials

Zelira Therapeutics (ASX:ZLD) has secured US$8.6 million (A$12.3 million) in cornerstone funding from a US-based investor to support its HOPE clinical trials.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News